← All trials
NCT01273584
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2010
- Primary completion
- Jul 1, 2015
- Completion date
- Sep 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 450
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Epsom and St Helier University Hospitals NHS TrustLead sponsor
- Epsom and St Helier University Hospitals NHS TrustOverall official - principal investigator
- Epsom and St Helier University Hospitals NHS TrustStudy director
- Fetal Medicine FoundationCollaborator
- University of LondonCollaborator
- Medway NHS Foundation TrustOverall official - principal investigator
- University of LondonOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.